INTRODUCTION AND OBJECTIVE: Recent studies have shown an inverse relationship with
serum PSA levels and body mass index (BMI). We examined the relationship of BMI and …

Serum prostate-specific antigen (PSA) is a diagnostic biomarker of prostate cancer and is
possibly associated with obesity. This study aimed to explore the relationships between …

Purpose PSA is known to be lowered in obese patients. There is a lack of data regarding
patients with prostate cancer. Our objective was to prospectively assess the relationship …

BACKGROUND Differential prostate‐specific antigen (PSA) testing practices according to
obesity‐related comorbid conditions may contribute to inconsistent results in studies of …

BACKGROUND Recent studies of men with prostate carcinoma suggest that obesity may be
associated with more advanced‐stage disease and lower overall survival rates. One …

Background and objectives: This study aimed to evaluate the impact of body mass index on
PCa outcomes in our institution and also to find if there are statistically significant differences …

Introduction: The association between obesity and clinically significant prostate cancer
(PCa) is still a matter of debate. In this study, we evaluated the effect of body mass index …

Background Active surveillance (AS) is an expectant management strategy for prostate
cancer (PCa). The impact of obesity on progression is not well characterized in this …

Prostate cancer is a complex, heterogeneous disease. Factors related to detection,
particularly PSA screening, further increase heterogeneity in the manifestation of the …

Background The association between obesity and aggressive forms of prostate cancer is
controversial. We compared preoperative body mass index (BMI) and prostate-specific …